Despite lacking canonical targets for biologic treatment, TNBC may demonstrate a higher tumor mutational burden (TMB), higher PD-L1 expression, and more tumor-infiltrating lymphocytes compared to other subtypes [36,37,38,39], which are associated with an increased response to immunotherapy [40]. Here, CD274 is linked to neoplasm.